943513-74-4

Upstream product

• 849122-56-1 [(R)-3-(4-[11-(7-nitrobenzo[1,2,5]oxadiazol-4-ylamino)undecyloxy]phenyl)-1-hydroxymethyl-1-methylpropyl]carbamic acid tert-butyl ester 
• 873302-96-6 {3-[4-(11-dibenzylamino-undecyloxy)-phenyl]-1-hydroxymethyl-1-methyl-propyl}-carbamic acid tert-butyl ester 
• 873302-90-0 (R)-2-Amino-2-methyl-4-{4-[11-(7-nitro-benzo[1,2,5]oxadiazol-4-ylamino)-undecyloxy]-phenyl}-butan-1-ol 
• 873303-00-5 {3-[4-(11-amino-undecyloxy)-phenyl]-1-hydroxymethyl-1-methyl-propyl}-carbamic acid tert-butyl ester 
• 849122-54-9 methanesulfonic acid 11-dibenzylaminoundecyl ester 
• 463952-35-4 [(R)-1-hydroxymethyl-3-(4-hydroxy-phenyl)-1-methyl-propyl]-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

NBD-labeled derivatives of the immunomodulatory drug FTY720 as tools for metabolism and mode of action studies

Fluorescently labeled chiral analogs of the immunomodulatory drug FTY720 and its corresponding phosphates with variable aliphatic spacers between the aromatic ring and the NBD label have been synthesized. Determining the influence of the spacer on the in